Diaran MR Modified-Release Tablets

    Diaran MR Modified-Release Tablets

    S3


    1. What DIARAN MR 30 is and what it is used for

    DIARAN MR 30 belongs to a group of medicines called sulphonylureas. Sulphonylureas are medicines, which cause blood sugar to decrease to normal levels in patients of diabetes where blood sugar is high and is not controlled by diet, physical exercise and weight loss alone.

    2. What you need to know before you take DIARAN MR 30

    Do not take DIARAN MR 30 if:

    • You have insulin dependent (type I) diabetes
    • You have a known allergy to gliclazide, to any of the other ingredients or to other sulphonylureas and related medicines.
    • You have had diabetic ketoacidosis (A rare but serious complication of high blood sugar levels that is rarely fatal. Deep rapid breathing and non-specific symptoms such as nausea, vomiting, stomach pain, a fruity breath odour, feeling faint or lightheaded. Insulin injections would be required to prevent further worsening of the condition)
    • You have/had severe kidney or liver disease
    • You are currently breast feeding
    • You are pregnant or planning to become pregnant
    • You are a child.
    • You are taking medicines to treat fungal infections (miconazole).

    Please consult your doctor, even if these statements were applicable to you at any time in the past.

    Warnings and precautions

    Take special care with DIARAN MR 30:

    • In the first few weeks of treatment the risk of having reduced blood sugar levels (hypoglycaemia) may be increased, so close monitoring is necessary.
    • Low blood sugar may occur:
      • If you are taking other medicines.
      • If you are under exceptional stress such as fever, trauma or any other surgical intervention which may affect your blood glucose control.
      • You are taking other hypoglycaemic medicines.
      • You skip meals, have periods of fasting or irregular mealtimes or change your diet
      • You do not balance physical exercise with your carbohydrate intake
      • You suffer from any endocrine disorder such as problems with your thyroid or glands that secrete hormones
      • Your kidney function is deteriorating
      • You drink alcohol, especially with skipped meals.
    • The use of oral hypoglycaemic agents (medicines to treat ‘sugar’ diabetes) may be associated with increased cardiac (heart) mortality as compared to treatment with diet alone or diet with insulin use.
    • If you have a family history of or known you have the hereditary condition glucose-6-phosphate dehydrogenase (G6PD) deficiency (abnormality of red blood cells), lowering of the haemoglobin level and breakdown or red blood cells (haemolytic anaemia) can occur. Contact your doctor before taking this medicine.
    • If you have the hereditary condition porphyria, acute porphyria can occur with the use of sulfonylurea medicines.

    3. How to take DIARAN MR 30

    Do not share medicines prescribed for you with any other person. Always take DIARAN MR 30 exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

    Your doctor may prescribe some blood tests before starting treatment with this medicine and during the course of your treatment to check your blood sugar and liver function.

    Swallow your tablet whole with a glass of water. Do not chew them.

    The usual dose is:

    The total daily dose can vary from one tablet to four tablets taken as a single daily dose. This depends on the response to treatment. All treatments for diabetes are lifelong.

    You should take your tablet(s) with breakfast and preferably at the same time each day.

    If you are currently using another medicine your doctor will decide on the dose of DIARAN MR 30 to take and whether you need to stop taking the other medicine.

    If you have the impression that the effect of DIARAN MR 30 tablet is too strong or too weak, talk to your doctor or pharmacist.

    If you have taken more DIARAN MR 30 than you should

    In the event of overdosage, consult your doctor or pharmacist. If neither is available, contact the nearest hospital or poison control centre. Take this leaflet or some tablets with you so your doctor will know what you have taken.

    If you forget to take DIARAN MR 30

    If you forget to take a tablet, take them as soon as you remember, do not increase your dose the next day. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take a double dose to make up for forgotten individual doses.

    If you stop taking DIARAN MR 30

    Do not stop taking DIARAN MR 30 without talking to your doctor.

    4. Possible side effects

    DIARAN MR 30 can have side effects. Not all side effects reported for DIARAN MR 30 are included in this leaflet. Should your general health worsen, or if you experience any untoward effects while taking DIARAN MR 30, please consult your health care provider for advice.

    Side effects are most likely to happen at the start of treatment. If any of the following happens, stop taking DIARAN MR 30 and tell your doctor immediately or go to the casualty department at your nearest hospital:

    • Rashes, hives, itching, chest constriction, shortness of breath or swelling of the face, lips, hands or feet, fainting, high temperature.

    These are all very serious side effects. If you have them, you may have had a serious reaction to DIARAN MR 30. You may need urgent medical attention or hospitalisation.

    Tell your doctor immediately or go to the casualty department at your nearest hospital if you notice any of the following:

    • Hypoglycemia characterized by tiredness, uncontrolled shaking, cold sweats, fast heart beat, feeling faint or lightheaded, hunger pangs, anxiety, inability to concentrate, blurred vision, or nervousness. If not treated promptly, may progress to confusion, or coma. If you experience any of these symptoms, you should immediately take sugar (glucose) tablets or sweetened juices.

    To avoid hypoglycemia do not miss or delay meals or change your diet, take more DIARAN MR 30 than needed, do a more intense, rigorous physical exercise or more work than normal.

    Yellowing of skin and whites of the eyes with decreased appetite and abdominal pain. These generally disappear if the medicine is stopped. These are all serious side effects. You may need urgent medical attention.

    Tell your doctor if you notice any of the following:

    • Nausea, vomiting, heartburn, loss of appetite, constipation, diarrhoea and a metallic taste. These side-effects are reduced when DIARAN MR 30 is taken with a meal as recommended.
    • Skin rashes and itching
    • Visual disturbances (may occur especially on initiation of treatment, due to changes in blood glucose levels).

    If you are unclear about any of the side-effects mentioned, you should discuss them with your doctor or pharmacist.

    There may be changes in the results of certain laboratory tests such as

    • Elevated liver enzymes
    • Decreased number of blood cells called leucocytes, platelets and low haemoglobin.

    If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.

    Reporting of side effects

    If you get side effects, talk to your doctor, pharmacist or nurse. You can also report side effects to SAHPRA via the “6.04 Adverse Drug Reaction Reporting Form”, found online under SAHPRA’s publications:

    https://www.sahpra.org.za/Publications/Index/8. By reporting side effects, you can help provide more information on the safety of DIARAN MR 30.

    5. How to store DIARAN MR 30

    Store all medicines out of reach of children.

    • Store at or below 25 °C.in the original package, protected from moisture.
    • Do not store in a bathroom.
    • Do not use after the expiry date stated on the label.
    • Return all unused medicine to your pharmacist.
    • Do not dispose of unused medicine in drains or sewerage systems e.g. toilets.
    Important Disclaimer

    The Diaran MR Modified-Release Tablets professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Diaran MR Modified-Release Tablets
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites